Home/ Stocks/ MGRX

Mangoceuticals, Inc. Common Stock

MGRX XNAS

$0.43 +0.00 (+0.00%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$9.30M

About Mangoceuticals, Inc. Common Stock

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Sector: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$68.8K	$-1,312,931	$-0.09
FY 2025	$456.0K	$-20,643,455	$-2.17
Q3 2025	$84.2K	$-7,618,776	$-0.69
Q2 2025	$168.1K	$-5,415,820	$-0.57

Earnings & Analyst Ratings

Next Earnings: Thu, Nov 12, 2026

Calendar →

Related Market News

No specific coverage for MGRX yet. Check out our latest market news or earnings calendar.

Get MGRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Mangoceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.